口服Gd-DTPA稀释液在2D-MRCP检查中的体内外实验
In vitro/in vivo Experiments of Oral Gd-DTPA Dilution in 2D-MRCP Examination
-
摘要: 目的 通过体外、体内实验研究, 筛选出2D-MRCP检查时口服Gd-DTPA稀释液作为胃肠道阴性对比剂的最佳浓度、容量及扫描时间.方法 (1) 体外研究:取静脉用Gd-DTPA注射液0.05、0.10、0.15和0.20m L, 稀释成浓度分别为0.25、0.50、0.75、1.00 mmol/L的溶液各100 m L;另备100 m L温开水作为对照组, 行2D-MRCP序列扫描, 测量不同浓度对比剂的信号强度及衰减率. (2) 体内研究:选取体外实验中显示最佳信号强度及衰减率的Gd-DTPA稀释液作为胃肠道阴性对比剂, 配制成50 m L及100 m L二种容量, 分别给2组患者口服后46 min、911 min行2D-MRCP扫描, 观察胃及十二指肠内高信号液体的抑制情况及患者服用对比剂后有无不良反应.结果 (1) 在口服浓度为1.00 mmol/L、容量为100 m L的Gd-DTPA稀释液后911 min行2D-MRCP扫描, 可完全抑制胃及十二指肠内高信号液体; (2) 口服Gd-DTPA稀释液配制简便, 口服量少, 服用后患者无任何不适反应, 是一种较为理想的口服胃肠道阴性对比剂.结论 口服适宜浓度、容量的Gd-DTPA稀释液在合适的检查时间行2D-MRCP序列扫描, 可有效抑制胃及十二指肠内液体的高信号影.Abstract: Objective To select the best concentration, volume and checking time of Gd-DTPA dilution as an oral negative gastrointestinal contrast agent by in vitro/in vivo experiments. Methods (1) In vitro experiments :we used 0.05, 0.10, 0.15 and 0.20 m L intravenous injections of Gd-DTPA, which were diluted into concentrations of 0.25, 0.50, 0.75, 1.00 mmol/L, then we examined and made a contrastive analysis about the signal intensity and attenuation rate of 2 D-MRCP with different concentration contrast agent. (2) In vivo experiments: we used the optimum concentration of Gd-DTPA dilution with 50 and 100 m L, made 2 D-MRCP scanning on 20 cases in two groups in 4-6 minutes and 9-11 minutes respectively after oral administration of Gd-DTPA dilution, and observed the restraint of the high signal liquid in stomach and duodenum, and whether the patients had adverse reactions. Results (1) It showed that the high signal liquid in stomach and duodenum of some patients with oral administration of 100 ml dilution with 1.00 mmol/L concentration could be fully restrained in 9-11 minutes. (2) The allocation of oral Gd-DTPA dilution is simple, the effect of restraining the high signal liquid in stomach and duodenum is well after oral administration of little dilution, and the patients have no adverse reactions, so it is a good oral gastrointestinal contrast agent.Conclusions 2 D-MRCP scanning in suitable time after oral administration of Gd-DTPA dilution with proper concentration and volume can effectively restrain the high signal liquid in stomach and duodenum.
-
Key words:
- MR cholangiopancreatography /
- Gadopentetate dimeglumine /
- Oraling /
- Concentraion /
- Volume /
- Checking time
-
[1] [1]MACCIONI F, MARTINELLI M, ANSARI N, et al.Magnetic resonance cholangiography:past, present and future:a review[J].Eur Rev Med Pharmacol, 2010, 14 (8) :721-725. [2]杨正汉, 冯逢, 王霄英.磁共振成像技术指南[M].第2版.北京:人民军医出版社, 2010:136. [3]程华才, 陈家祥, 张宏伟.三种胰胆管水成像技术优缺点及提高成像质量对策[J].中国CT和MRI杂志, 2013, 11 (6) :69-71. [4] 柏树令, 应大君.系统解剖学[M].第8版.北京:人民卫生出版社, 2015:123. [5]叶涛, 梁宗辉, 尉轶曼, 等.新型阴性口服对比剂在MRCP质量控制中的比较研究[J].影像质控与安全, 2014, 24 (5) :441-445. [6]许乙凯.磁共振对比剂及临床应用[M].北京:北京人民卫生出版社, 2003:15-22. [7]陈江.口服静脉用钆喷酸葡胺在MRCP检查中的应用[J].华夏医学, 2013, 26 (1) :117-119. [8] [8]BITTMAN M E, CALLAHAN M J.The effective use of Gd-DTPA as negative contrast agents for magnetic Resonance cholangiopancreatography[J].Pediatric radiology, 2014, 44 (6) :883-887. [9] [9]SINGH V, SINGH G, GUPTA V.et a1.Contrast free air cholangiography assisted unilateral plastic stenfing in malignant hilar bihary obstruction[J].Hepatobiliary Pancreat Dis Int, 2010, 9 (6) :88-92. [10]李岭, 于金芬, 鲁德会, 等.静脉注射联合口服钆喷酸葡胺磁共振胆胰管成像在低场强MR的应用[J].医学影像学杂志, 2012, 22 (3) :430-433. [11]陈翼, 许乙凯.口服静脉用钆喷酸葡胺改善MRCP图像质量研究[J].实用医学杂志, 2008, 24 (5) :762-764. [12]王洪生.MRCP胃肠道内口服对比剂的类型及应用[J].上海交通大学学报 (医学版) , 2007, 6 (27) :751-754. [13]林红霞, 陈骐.磁共振成像对比剂的研究进展[J].沈阳药科大学学报, 2012, 19 (2) :138-142. [14] [14]MORITA S, UENO E, MASUKAWA A, et a1.Prospective comparative study of negative oral contrast agents for magnetic resonance cholangiopancreatography[J].Jpn J Radiol, 2010, 28 (6) :117-122. [15]陆军媛, 樊树锋, 刘春蛾, 等.碘过敏患者磁共振钆对比剂过敏性休克致死一例[J].放射学实践, 2011, 26 (8) :835.
点击查看大图
计量
- 文章访问数: 2176
- HTML全文浏览量: 813
- PDF下载量: 55
- 被引次数: 0